Latest Blogs

Sep 17, 2020
"The post-COVID world of medicine is a place of nuance at the new, tech-driven intersection of love and science," writes Dr. Douglas B. Flora of the virtual house call.
Sep 15, 2020
Dr. Deborah Mukherji and Dr. Sally Temraz conducted a survey which examined representation and barriers to women oncologists in the Middle East, and surfaced ideas for improving gender parity in the field.
Sep 10, 2020
My own recent hospitalization led me to reflect on the profound and essential role that nurses have had on my life. They have left an indelible imprint on my subconscious, and inspired the following poem.
Sep 09, 2020
"The COVID-19 pandemic’s impact is immediate for people who suffered from infection, but there is also an indirect impact on people who had to defer diagnosis and treatment plans, and the consequences of these delays will likely last for years," Dr. Dawood Findakly writes.
Subscribe to this column

L. Michael Glode, MD, FACP, FASCO

L. Michael Glodé, MD, FACP, FASCO, is a Professor Emeritus at the University of Colorado Cancer Center. He previously served as Chair of ASCO's Integrated Media and Technology and Cancer Education Committees. He is the author of prost8blog, a blog to help patients and their families understand various aspects of prostate cancer.

Jun 02, 2014
Adding 6 cycles of docetaxel at the outset of hormonal therapy for prostate cancer has been shown to improve survival, especially in men with a high burden of disease. The much-...
Apr 18, 2014
So how did the robot take over? As I recall, it started with "hospital A" buying the fancy robot for their urologists to use, after said urologists insisted that this was the way of the future. The Intuitive Surgical Company did an...
Mar 10, 2014
A new article appeared this week with further fuel for those on the side of intervention (and by implication, pro-screening). Let's remember before we get started that the two...
Feb 07, 2014
Long, long ago, I had just finished my fellowship in medical oncology and moved from Boston to Denver. In the lab, I was working on an obscure enzyme that seemed to differentiate leukemia from normal cells,cystathionase. In...
Jan 15, 2014
These two questions are among the most commonly asked in my clinic, particularly from patients who are recently diagnosed with prostate cancer.
Jun 04, 2012
Since I have no formal training in either of these disciplines, it is either possible (or likely) that I will say things that offend both camps. In three of the presentations at ASCO this week in which I have great interest professionally (prostate cancer), questions have arisen that bring these...

Pages